Council Working Group on the IOM Report: The CTSA Program at NIH

At the suggestion of Congress, NIH commissioned an Institute of Medicine (IOM) study in July 2012 to review the Clinical and Translational Science Awards (CTSA) program. On June 25, 2013, the IOM released its report, which provides recommendations to build on the successes of the program and realize its full potential for transforming translational science for the benefit of human health. To provide guidance on these recommendations, NCATS established the Advisory Council Working Group on the IOM Report: The CTSA Program at NIH. This group provided advice on changes to the CTSA program, with a focus on establishing measurable goals and objectives.

The working group included both council and non-council members who have extensive expertise in the subject areas addressed in the IOM report. Their insights and perspective were critical to the evolution of the CTSA program and to NCATS, and more broadly, to the biomedical research community. On May 16, 2014, the working group issued a report (PDF - 414KB) in response to the IOM's findings. NCATS released a related statement from the director.

Having completed its assigned tasks, this working group now is disbanded.

Working Group Members


Ronald J. Bartek
FARA/Friedreich’s Ataxia Research Alliance

Mary L. (Nora) Disis, M.D.
Professor, Department of Medicine
Division of Oncology
University of Washington School of Medicine

Scott J. Weir, Pharm.D., Ph.D.
Director, Institute for Advancing Medical Innovation
University of Kansas Cancer Center


Ann Bonham, Ph.D.
Chief Scientific Officer
Association of American Medical Colleges

Matthew Davis, M.D., M.P.P.
Professor of Pediatrics and Communicable Diseases and Professor of Internal Medicine, Medical School
Professor of Public Policy, Gerald R. Ford School of Public Policy
University of Michigan
Chief Medical Executive, Michigan Department of Community Health

David L. DeMets, Ph.D.
Professor, Department of Biostatistics & Medical Informatics
University of Wisconsin

Gary H. Gibbons, M.D.
Director, National Heart, Lung, and Blood Institute
National Institutes of Health

Robert A. Harrington, M.D.
Arthur L. Bloomfield Professor of Medicine
Chair, Department of Medicine
Stanford University

Philip L. Lee, J.D., M.P.M.
Results Leadership Group

Lynn Marks, M.D.
Senior Vice President, Projects, Clinical Platforms & Sciences, GlaxoSmithKline
Corporate Secretary  & Chair of the Operations Committee, TransCelerate Biopharma

Sharon Milgram, Ph.D.
Director, Office of Intramural Training and Education
National Institutes of Health

Louis J. Muglia, M.D., Ph.D.
Co-Director, Perinatal Institute, Division of Neonatology
Director, Center for Prevention of Preterm Birth
Professor, University of Cincinnati Department of Pediatrics
Cincinnati Children’s Hospital

Fernando Pineda-Reyes
CEO and Founder
CREA Results

Robert I. Tepper, M.D.
Third Rock Ventures, LLC